MoonLake Immunotherapeutics MLTX Trade and other payables
Trade and other payables at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept mnlk:TradeAndOtherPayablesCurrent.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's trade and other payables.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's trade and other payables?
- MoonLake Immunotherapeutics (MLTX) reported trade and other payables of $23.38M in Q1 2026.
- How has MoonLake Immunotherapeutics's trade and other payables changed year-over-year?
- MoonLake Immunotherapeutics's trade and other payables increased by 94.7% year-over-year, from $12.01M to $23.38M.
- What is the long-term trend for MoonLake Immunotherapeutics's trade and other payables?
- Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's trade and other payables has grown at a 108.3% compound annual growth rate (CAGR), from $1.57M to $29.55M.
- What does trade and other payables mean?
- This metric represents the total short-term financial obligations owed to suppliers, vendors, and service providers for goods and services received in the ordinary course of business. It serves as a key indicator of a company's working capital management and its short-term liquidity position regarding operational expenses. Monitoring this balance helps investors assess the company's ability to manage its trade credit and maintain healthy relationships with its supply chain partners.